| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |